Loading...
XNYSCLW
Market cap472mUSD
Jan 14, Last price  
28.50USD
1D
-1.35%
1Q
1.82%
Jan 2017
-56.52%
IPO
160.75%
Name

Clearwater Paper Corp

Chart & Performance

D1W1MN
XNYS:CLW chart
P/E
4.38
P/S
0.23
EPS
6.50
Div Yield, %
0.00%
Shrs. gr., 5y
0.72%
Rev. gr., 5y
3.85%
Revenues
2.08b
+0.13%
1,106,681,0001,173,326,0001,255,309,0001,250,069,0001,372,965,0001,927,973,0001,874,304,0001,889,830,0001,967,139,0001,752,401,0001,734,763,0001,730,408,0001,724,218,0001,761,500,0001,868,600,0001,772,600,0002,080,100,0002,082,800,000
Net income
108m
+134.13%
21,125,00025,566,0009,743,000182,464,00073,800,00039,674,00064,131,000106,955,000-2,315,00055,983,00049,554,00097,339,000-143,767,000-5,600,00077,100,000-28,000,00046,000,000107,700,000
CFO
191m
+26.96%
96,171,000108,668,00042,058,000224,764,000185,591,00068,395,000198,693,000136,357,000139,100,000159,675,000172,751,000177,670,000168,899,00055,600,000247,000,00096,400,000150,200,000190,700,000
Earnings
Feb 18, 2025

Profile

Clearwater Paper Corporation manufactures and supplies bleached paperboards, and consumer and parent roll tissues in the United States and internationally. It operates through two segments, Pulp and Paperboard, and Consumer Products. The Pulp and Paperboard segment offers folding cartons, liquid packaging, cups and plates, blister and carded packaging products, top sheet and commercial printing items, and softwood pulp products, as well as custom sheeting, slitting, and cutting of paperboard products. It sells its products to packaging converters, folding carton converters, merchants, and commercial printers. The Consumer Products segment provides a line of at-home tissue products, including bath tissues, paper towels, facial tissues, and napkins; recycled fiber value grade products; and away-from-home tissues. This segment sells its products to retailers and wholesale distributors, including grocery, club, mass merchants, and discount stores. Clearwater Paper Corporation was incorporated in 2005 and is headquartered in Spokane, Washington.
IPO date
Dec 05, 2008
Employees
3,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,082,800
0.13%
2,080,100
17.35%
Cost of revenue
1,901,200
1,956,400
Unusual Expense (Income)
NOPBT
181,600
123,700
NOPBT Margin
8.72%
5.95%
Operating Taxes
36,400
27,000
Tax Rate
20.04%
21.83%
NOPAT
145,200
96,700
Net income
107,700
134.13%
46,000
-264.29%
Dividends
Dividend yield
Proceeds from repurchase of equity
(17,900)
(5,000)
BB yield
2.90%
0.77%
Debt
Debt current
16,200
900
Long-term debt
526,400
576,900
Deferred revenue
Other long-term liabilities
206,000
58,200
Net debt
500,600
559,800
Cash flow
Cash from operating activities
190,700
150,200
CAPEX
(73,700)
(33,500)
Cash from investing activities
(73,700)
(33,500)
Cash from financing activities
(129,400)
(88,600)
FCF
81,200
149,400
Balance
Cash
42,000
53,700
Long term investments
(35,700)
Excess cash
Stockholders' equity
653,800
543,500
Invested Capital
1,402,000
1,196,000
ROIC
11.18%
8.03%
ROCE
12.95%
8.88%
EV
Common stock shares outstanding
17,091
17,181
Price
36.12
-4.47%
37.81
3.11%
Market cap
617,327
-4.97%
649,614
5.65%
EV
1,117,927
1,209,414
EBITDA
280,200
227,000
EV/EBITDA
3.99
5.33
Interest
32,400
34,600
Interest/NOPBT
17.84%
27.97%